Newsroom

Keep up with the latest

Featured

This Scientist Is Building Custom Gene-Editing Tools

This Scientist Is Building Custom Gene-Editing Tools

Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025

November 17, 2025

Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025

November 17, 2025

Epigenetic editors are a gentler form of gene editing

February 24, 2025

The Economist

Epigenetic editors are a gentler form of gene editing

February 24, 2025

CRISPR 2.0, the Next Generation

June 21, 2024

Aspen Ideas: Health

CRISPR 2.0, the Next Generation

June 21, 2024

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

TEDxBerkeley

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

Media Center

All
Media Highlights
Press Releases
Media

Scribe’s cardiometabolic programs gain CIRM boost

June 19, 2026

BioWorld

Read Now
Media

Scribe advances safer CRISPR therapies for heart health

May 22, 2026

Longevity.Technology

Read Now
Media

‘Unbelievably cool’: New therapy aims to lower ‘bad’ cholesterol before it turns deadly

May 22, 2026

Herald Sun

Read Now
Media

Genome editing can be risky. Meet the epigenome editors

April 29, 2026

The Economist

Read Now
Media

Scribe Therapeutics Positions Epigenetic CRISPR for Durable LDL-C Reduction

March 25, 2026

CRISPR Medicine News

Read Now
Media

Scribe and Eli Lilly Reach Second Milestone in In Vivo CRISPR Collaboration

February 17, 2026

BioPharmaTrend

Read Now
Press release

Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

March 6, 2024

Read Now
Press release

Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target

January 3, 2024

Read Now
Press release

Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

Read Now
Press release

Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology

December 20, 2023

Read Now
Press release

Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases

July 17, 2023

Read Now
Press release

Scribe Therapeutics to Participate in Upcoming Investor Conferences in May and June

May 22, 2023

Read Now

Publications